High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

<div>Overall progression-free survival (PFS) of patients treated with high-dose prolonged-infusion ifosfamide chemotherapy (11 patients). Median PFS was 1.9 months.</div>

Sarcoma

fig3

Figure 3

Figure 3: High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma 